MedTech Blunders in Risk Management
Risk management has traditionally involved siloes, with some difference in perspective from industry to regulators to standards bodies. With a movement toward speaking the same language, device companies should also reexamine their approach to risk management. “When we think about designing or manufacturing….our intent is good minded [and] I think it’s risk based, but some times our documentation, our records [and] our activities don’t always align with our intent,” explained Jon Speer, founder and vice president of QA/RA at greenlight.guru during the MedTech Intelligence risk management conference last month. “And sometimes our activities are simply checkbox activities.”
What other mistakes do companies make? Watch the video to find out.
Related Articles
-
Risk Management is the single most important topic impacting the medical device industry today.
-
Medtech companies should be taking a broad approach to assessing risk.
-
There’s a greater emphasis on being able to demonstrate competence in performing required activities.
-
Roberta Goode, president & CEO of Goode Compliance International, weighs in on the latest challenges medical device manufacturers are facing in risk management at the MedTech Intelligence HHE, Risk Assessment, & Recalls Conference in Washington, DC.
-
Differing approaches to risk could hamper further growth of combination products.
-
A review of the important aspects of risk management and post-market surveillance processes, and how to resolve common concerns.
